Coinbase
COIN
Strategy
MSTR
Tesla
TSLA
Salesforce
CRM
NVIDIA
NVDA
US Stock MarketDetailed Quotes
EYPT EyePoint Pharmaceuticals
- 7.080
- -0.010-0.14%
Trading Mar 11 12:02 ET
486.60MMarket Cap-3.05P/E (TTM)
7.270High6.880Low235.99KVolume7.090Open7.090Pre Close1.67MTurnover0.54%Turnover RatioLossP/E (Static)68.73MShares23.97052wk High1.45P/B308.28MFloat Cap5.54052wk Low--Dividend TTM43.54MShs Float72.200Historical High--Div YieldTTM5.50%Amplitude2.190Historical Low7.075Avg Price1Lot Size
About EyePoint Pharmaceuticals Company
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
Company Profile
SymbolEYPT
Company NameEyePoint Pharmaceuticals
Listing DateJan 27, 2005
Founded1987
CEODr. Jay S. Duker, M.D.
MarketNASDAQ
Employees165
Fiscal Year Ends12-31
Address480 Pleasant Street,Suite A-210
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-926-5000
Company Executives
- Name
- Position
- Salary
- Dr. Jay S. Duker, M.D.
- Director, President and Chief Executive Officer
- 2.92M
- George O. Elston
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 1.78M
- Dr. Ramiro Ribeiro, M.D.,PhD
- Chief Medical Officer
- --
- Dr. Goran A. Ando, M.D.
- Chairman of the Board
- 214.78K
- Nancy S. Lurker
- Executive Vice Chairman of the Board
- 3.74M
- Dr. Reginald Sanders, M.D.
- Director
- --
- Fred Hassan
- Director
- --
- Dr. John B. Landis, PhD
- Director
- 161.67K
- Karen Zaderej
- Independent Director
- 149.17K
- Wendy F. DiCicco
- Independent Director
- 171.67K
- Stuart M. Duty
- Independent Director
- 381.10K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.